resiquimod has been researched along with orabase in 1 studies
Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (orabase) | Trials (orabase) | Recent Studies (post-2010) (orabase) |
---|---|---|---|---|---|
465 | 14 | 318 | 3,694 | 227 | 1,883 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carter, D; Chung, NP; Klasse, PJ; Matthews, K; Moore, JP; Moutaftsi, M; Reed, SG; Salazar, AM; Sanders, RW | 1 |
1 other study(ies) available for resiquimod and orabase
Article | Year |
---|---|
Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cells.
Topics: Adjuvants, Immunologic; Adult; Aged; B-Lymphocytes; Carboxymethylcellulose Sodium; Cell Polarity; Cell Proliferation; Cells, Cultured; Coculture Techniques; Cytokines; Drug Synergism; HIV Envelope Protein gp120; Humans; Imidazoles; Langerhans Cells; Lipid A; Lipopolysaccharide Receptors; Lymphocyte Activation; Middle Aged; Poly I-C; Polylysine; Skin; Toll-Like Receptors; Vaccination; Young Adult | 2013 |